Janet Rehnquist - 28 Dec 2023 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Janet Rehnquist
Issuer symbol
NRXP
Transactions as of
28 Dec 2023
Net transactions value
$0
Form type
3
Filing time
16 Jan 2024, 18:36:17 UTC

No securities are beneficially owned.